UBIRed is an innovative network dedicated to enhancing the quality and impact of research on ubiquitin and ubiquitin-like proteins (UBLs) in Spain. These proteins play a crucial role in various cellular processes, including cell proliferation, differentiation, and responses to stress and immune challenges. Given their association with diseases like cancer, there is a growing interest among pharmaceutical companies to develop therapies that target UBL activities.

To address the complex scientific questions surrounding UBLs, UBIRed brings together expert research teams across Spain to foster collaboration and technological advancement. The network aims to promote the transfer of knowledge from fundamental research to applied science, leading to the creation of new diagnostic and therapeutic techniques. By pursuing these objectives, UBIRed aspires to amplify Spanish leadership in this competitive field and facilitate the translation of groundbreaking scientific discoveries into practical medical solutions that enhance human health.

Through collaborative efforts and integrated approaches, UBIRed is positioned to significantly influence cancer research and treatment